Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy

DSpace/Manakin Repository

Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy

Citable link to this page

 

 
Title: Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
Author: Stankov, Metodi V.; Khatib, Mona El; Thakur, Basant Kumar; Heitmann, Kirsten; Panayotova-Dimitrova, Diana; Schoening, Jennifer; Bourquin, Jean-Pierre; Schweitzer, Nora; Leverkus, Martin; Welte, Karl; Reinhardt, Dirk; Li, Zhe; Orkin, Stuart H.; Behrens, Georg M.N.; Klusmann, Jan-Henning

Note: Order does not necessarily reflect citation order of authors.

Citation: Stankov, M. V., M. E. Khatib, B. K. Thakur, K. Heitmann, D. Panayotova-Dimitrova, J. Schoening, J. Bourquin, et al. 2014. “Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy.” Leukemia 28 (3): 577-588. doi:10.1038/leu.2013.264. http://dx.doi.org/10.1038/leu.2013.264.
Full Text & Related Files:
Abstract: Histone deacetylase (HDAC)-inhibitors (HDACis) are well characterized anti-cancer agents with promising results in clinical trials. However, mechanistically little is known regarding their selectivity in killing malignant cells while sparing normal cells. Gene expression-based chemical genomics identified HDACis as being particularly potent against Down syndrome associated myeloid leukemia (DS-AMKL) blasts. Investigating the anti-leukemic function of HDACis revealed their transcriptional and posttranslational regulation of key autophagic proteins, including ATG7. This leads to suppression of autophagy, a lysosomal degradation process that can protect cells against damaged or unnecessary organelles and protein aggregates. DS-AMKL cells exhibit low baseline autophagy due to mTOR activation. Consequently, HDAC inhibition repressed autophagy below a critical threshold, which resulted in accumulation of mitochondria, production of reactive oxygen species, DNA-damage and apoptosis. Those HDACi-mediated effects could be reverted upon autophagy activation or aggravated upon further pharmacological or genetic inhibition. Our findings were further extended to other major acute myeloid leukemia subgroups with low basal level autophagy. The constitutive suppression of autophagy due to mTOR activation represents an inherent difference between cancer and normal cells. Thus, via autophagy suppression, HDACis deprive cells of an essential pro-survival mechanism, which translates into an attractive strategy to specifically target cancer cells.
Published Version: doi:10.1038/leu.2013.264
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947652/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12987310
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters